Last reviewed · How we verify
Piece of kidney removal
Piece of kidney removal is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 2 development.
At a glance
| Generic name | Piece of kidney removal |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
- High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy (NA)
- First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Piece of kidney removal CI brief — competitive landscape report
- Piece of kidney removal updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Piece of kidney removal
What is Piece of kidney removal?
Piece of kidney removal is a Biologic drug developed by Assistance Publique - Hôpitaux de Paris.
Who makes Piece of kidney removal?
Piece of kidney removal is developed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).
What development phase is Piece of kidney removal in?
Piece of kidney removal is in Phase 2.